S-1 Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q2 2014

Filing Information

Form Type	S-1
Accession Number	`0001121781-14-000293`
Period End Date	20140630
Filing Date	20140915
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	gthp-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 117 Income Statement 116 Cash Flow Statement 122 Stockholders Equity 25

Balance Sheet 117 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$25.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$184.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $25 and $18 at June 30, 2014 and December 31, 2013 and December 31, 2012, respectively	`AccountsReceivableNet`	$133.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$119.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $25 and $18 at June 30, 2014 and December 31, 2013 and December 31, 2012, respectively	`AccountsReceivableNet`	$233.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $25 and $18 at June 30, 2014 and December 31, 2013 and December 31, 2012, respectively	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Inventory, net of reserves of $ 119 and $184 and $52, at June 30, 2014 and December 31, 2013 and December 31.2012, respectively.	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Inventory, net of reserves of $ 119 and $184 and $52, at June 30, 2014 and December 31, 2013 and December 31.2012, respectively.	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.19M	USD	Point-in-time
Inventory, net of reserves of $ 119 and $184 and $52, at June 30, 2014 and December 31, 2013 and December 31.2012, respectively.	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.12M	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$101.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$13.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.85M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$804.00K	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$920.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1,737.00	shares	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1,532.00	shares	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1,532.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$343.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$356.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1,737.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Debt issuance cost, net	`DeferredFinanceCostsNet`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Debt issuance cost, net	`DeferredFinanceCostsNet`	$825.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.28M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.97M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62,282.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.82M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	75.50M	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	70.48M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.32M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62,282.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	75.50M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	70.48M	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$35.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$282.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$160.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$109.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Notes payable - past due	`NotesPayableCurrent`	$419.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$891.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$980.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$723.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$28.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$14.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.77M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.05M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.55M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	-	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$103.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$4.00K	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$2.75M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.65M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$3.80M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$6.32M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$2.35M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$3.42M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 1,532 and 1,737 and zero shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively (liquidation preference of $1.5 million and $2.1 million and 0 as of June 30, 2014 and December 31, 2013 and 2012, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$1.14M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 1,532 and 1,737 and zero shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively (liquidation preference of $1.5 million and $2.1 million and 0 as of June 30, 2014 and December 31, 2013 and 2012, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 1,532 and 1,737 and zero shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively (liquidation preference of $1.5 million and $2.1 million and 0 as of June 30, 2014 and December 31, 2013 and 2012, respectively).	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$813.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 75,495,469 and 70,478,961 and 62,282 shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively.	`CommonStockValue`	$62.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 75,495,469 and 70,478,961 and 62,282 shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively.	`CommonStockValue`	$75.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000,000 shares authorized, 75,495,469 and 70,478,961 and 62,282 shares issued and outstanding as of June 30, 2014 and December 31, 2013 and December 31, 2012, respectively.	`CommonStockValue`	$71.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$101.84M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$103.58M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-103.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-106.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`StockholdersEquity`	$-107.00K	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`StockholdersEquity`	$1.13M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`StockholdersEquity`	$1.58M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-107.00K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.49M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.82M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.32M	USD	Point-in-time

Income Statement 116 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$3.34M	USD	Annual
Contract and grant revenue	`Revenues`	$222.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$389.00K	USD	2 Qtrs
Contract and grant revenue	`Revenues`	$820.00K	USD	Annual
Contract and grant revenue	`Revenues`	$11.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$30.00K	USD	2 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$201.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$323.00K	USD	2 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$72.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$359.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$116.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$248.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$271.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$117.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$277.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$611.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$119.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$463.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-70.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-29.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-140.00K	USD	2 Qtrs
Gross Loss	`GrossProfit`	$-252.00K	USD	Annual
Gross Loss	`GrossProfit`	$-3.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-45.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.23M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.23M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$624.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$834.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$901.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$345.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$195.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$628.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$424.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$359.00K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.92M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.97M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.53M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$999.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$931.00K	USD	1 Quarter
Total	`OperatingExpenses`	$1.97M	USD	1 Quarter
Total	`OperatingExpenses`	$7.17M	USD	Annual
Total	`OperatingExpenses`	$4.00M	USD	2 Qtrs
Total	`OperatingExpenses`	$7.57M	USD	Annual
Total	`OperatingExpenses`	$1.96M	USD	1 Quarter
Total	`OperatingExpenses`	$3.98M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.03M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.11M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.61M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.62M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.28M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.74M	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$3.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	-	USD	Annual
OTHER INCOME	`OtherIncome`	$75.00K	USD	2 Qtrs
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$5.00K	USD	2 Qtrs
OTHER INCOME	`OtherIncome`	$110.00K	USD	Annual
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$461.00K	USD	2 Qtrs
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$-81.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$-674.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$74.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$72.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$9.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$45.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$24.00K	USD	2 Qtrs
INTEREST EXPENSE	`InterestExpense`	$47.00K	USD	1 Quarter
Total other income	`TotalOtherIncome`	$-609.00K	USD	Annual
Total other income	`TotalOtherIncome`	$-72.00K	USD	Annual
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$7.21M	USD	Annual
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.75M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$4.35M	USD	Annual
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$2.15M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$3.71M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$3.56M	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-4.35M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-7.21M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-2.15M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.75M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-3.71M	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-3.17M	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.17M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-89.00K	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.17M	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-41.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.92M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.35M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.80M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.19M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.39M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.74M	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	65,884.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	72,986.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	65,675.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	64,678.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	72,223.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	57,429.00	shares	Annual

Cash Flow Statement 122 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.21M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	2 Qtrs
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	2 Qtrs
Bad debt expense (recovery)	`BadDebtRecovery`	$-3.00K	USD	Annual
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	Annual
Bad debt expense (recovery)	`BadDebtRecovery`	$22.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$361.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$300.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$461.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$227.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$824.00K	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$569.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$546.00K	USD	2 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	-	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$674.00K	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-496.00K	USD	2 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	-	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-74.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$4.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$94.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$669.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$33.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-13.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$76.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$100.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$144.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-97.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-88.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-83.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$172.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$221.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-337.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$126.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-36.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$14.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-26.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-413.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$223.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$513.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-59.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$257.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$25.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-55.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-13.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$50.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$792.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$299.00K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.66M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$890.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-3.67M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-5.56M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.77M	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$107.00K	USD	Annual
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$552.00K	USD	Annual
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$101.00K	USD	2 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$119.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-119.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-107.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-552.00K	USD	Annual
Proceed from debt financing, net of issuance costs	`ProceedsFromIssuanceOfDebt`	$86.00K	USD	Annual
Proceed from debt financing, net of issuance costs	`ProceedsFromIssuanceOfDebt`	$115.00K	USD	Annual
Proceed from debt financing, net of issuance costs	`ProceedsFromIssuanceOfDebt`	$3.19M	USD	2 Qtrs
Proceed from debt financing, net of issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.21M	USD	Annual
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	Annual
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.21M	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.83M	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$3.10M	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$3.28M	USD	Annual
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$446.00K	USD	2 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$237.00K	USD	2 Qtrs
Payments made on notes payables	`RepaymentsOfNotesPayable`	$125.00K	USD	Annual
Payments made on notes payables	`RepaymentsOfNotesPayable`	$374.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.81M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.81M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.23M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.06M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.16M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-128.00K	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-432.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$936.00K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$485.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$48.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	$9.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$20.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$31.00K	USD	Annual
Acquisition of minority interest	`AcquisitionOfMinorityInterest`	$104.00K	USD	Annual
Acquisition of minority interest	`AcquisitionOfMinorityInterest`	-	USD	Annual
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$162.00K	USD	Annual
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	2 Qtrs
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$66.00K	USD	2 Qtrs
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$126.00K	USD	Annual
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$89.00K	USD	2 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	-	USD	Annual
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$3.15M	USD	Annual
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$1.17M	USD	2 Qtrs
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	-	USD	Annual
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	$50.00K	USD	Annual
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	Annual
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	Annual
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	2 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	2 Qtrs
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	$2.66M	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	$537.00K	USD	Annual

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-107.00K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time
Issuance of Series B preferred stock, Amount	`IssuanceOfSeriesBPreferredStockAmount`	$1.34M	USD	Annual
Preferred dividends	`PreferredDividends`	$-27.00K	USD	Annual
Issuance of common stock, Amount	`IssuanceOfCommonStockAmount`	$162.00K	USD	Annual
Issuance of common stock, Amount	`IssuanceOfCommonStockAmount`	$463.00K	USD	Annual
Issuance of stock options	`IssuanceOfStockOptions`	$126.00K	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$3.10M	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$3.28M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$824.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$569.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$546.00K	USD	2 Qtrs
Stock-based compensation expense, Amount	`StockbasedCompensationExpenseAmount`	$824.00K	USD	Annual
Acquisition of minority interest	`AdjustmentToAdditionalPaidInCapitalAcquistionOfMinorityInterest`	$-28.00K	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net Loss	`NetIncomeLoss`	$-7.21M	USD	Annual
Net Loss	`NetIncomeLoss`	$-2.15M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.75M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.71M	USD	2 Qtrs
Ending Balance, Amount	`StockholdersEquity`	$-107.00K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.